{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T19:37:36Z","timestamp":1771011456025,"version":"3.50.1"},"reference-count":119,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2008,6,28]],"date-time":"2008-06-28T00:00:00Z","timestamp":1214611200000},"content-version":"vor","delay-in-days":4593,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Medicine"],"published-print":{"date-parts":[[1995,12]]},"abstract":"<jats:p><jats:bold>SUMMARY. <\/jats:bold> Conventional treatment of beta thalassaemia major is based on regular blood transfusion from early childhood. Maximum effectiveness of transfusion therapy depends on the following. (1) Availability of safe blood. Donation programmes should aim at retaining repeat donors, who carry decreased risk of transmitting blood\u2010borne infections. Donors should be screened with laboratory tests performed to the highest possible standard of quality. Selection of safe donors can be improved by the adoption of questionnaires containing direct questions on risk factors for transfusion transmissible infections. (2) Use of good quality red blood cells, which should be leucodepleted, preferably by filtration, that can be carried out at the bedside. (3) Regular evaluation of blood transfusion indices, including mean level of haemoglobin maintained, annual blood requirement, daily haemoglobin fall, mean transfusion interval, transfusion reaction rate. This can be assisted by the use of a computerized patient record. (4) Maintenance of a permanent record of the patient's blood group genotype (including at least Rh, Kell, Kidd and Duffy systems) and any red cell antibodies that develop. This is mandatory to ensure optimal survival of transfused red cells. (5) Continuous monitoring of transfusion transmissible infections. (6) Vaccination against hepatitis B of all suitable patients. (7) Intensive iron chelation. This should be done by regular subcutaneous administration of desferoxamine B. Oral chelators, which are currently under laboratory and clinical evaluation, are not yet available for general use.<\/jats:p>","DOI":"10.1111\/j.1365-3148.1995.tb00210.x","type":"journal-article","created":{"date-parts":[[2008,4,10]],"date-time":"2008-04-10T10:12:31Z","timestamp":1207822351000},"page":"247-258","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Blood transfusion in beta thalassaemia major"],"prefix":"10.1111","volume":"5","author":[{"given":"P.","family":"Rebulla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0887-7963(88)70051-6"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01696350"},{"key":"e_1_2_1_4_1","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1182\/blood.V80.3.593.593","article-title":"Efficacy and possible adverse effects of the oral iron chelator 1,2\u2010dimethyl\u20103\u2010hydroxypyrid\u20104\u2010one (L1) in thalassemia major","volume":"80","author":"Al\u2010Refaie F.N.","year":"1992","journal-title":"Blood"},{"key":"e_1_2_1_5_1","first-page":"342","article-title":"Review of serologic testing for hepatitis C virus infection and risk of posttransfusion hepatitis C","volume":"118","author":"Alter M.J.","year":"1994","journal-title":"Archives of Pathology & Laboratory Medicine"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1159\/000205170"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1246-7820(05)80055-2"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1990.tb07888.x"},{"key":"e_1_2_1_9_1","first-page":"63","volume-title":"Thalassemia 1990","author":"Berdoukas V.A.","year":"1991"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)92443-W"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2257.1986.tb00097.x"},{"key":"e_1_2_1_12_1","first-page":"41","volume-title":"Thalassemia 1990","author":"Berdoukas V.A.","year":"1991"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1140-4639(05)80191-1"},{"key":"e_1_2_1_14_1","first-page":"115","article-title":"Prise en charge des beta\u2010thalassemies dans un pays en voie de developpement. Experience d'un service de pediatrie d'Oran (Algerie)","volume":"39","author":"Bouhass R.A.","year":"1992","journal-title":"Annales de Pediatrie (Paris)"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V78.1.246.246"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1957.02980250053013"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1990.30891020335.x"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1990.30991048791.x"},{"key":"e_1_2_1_19_1","first-page":"58","article-title":"Thalassemia intermedia","volume":"80","author":"Camaschella C.","year":"1995","journal-title":"Haematologica"},{"key":"e_1_2_1_20_1","volume-title":"Management protocol for the treatment of thalassemia patients","author":"Cao A.","year":"1992"},{"key":"e_1_2_1_21_1","first-page":"271","article-title":"Deferoxamine in thalassemia major","volume":"332","author":"Cazzola M.","year":"1995","journal-title":"New England Journal of Medicine"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.2523562"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01732885"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(89)80353-1"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1994.34694295068.x"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V57.3.599.599"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1992.tb08181.x"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0950-3536(05)80164-7"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1989.29990070177.x"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1992.32692367192.x"},{"key":"e_1_2_1_31_1","first-page":"159","article-title":"Intensification du traitement chelateur de fer par la desferrioxamine a l'aide d'une chambre implantable d'access veineux","volume":"49","author":"Montalembert M.","year":"1992","journal-title":"Archives Fran\u00e7aises de Pediatrie"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1994.tb00290.x"},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1992.32392213801.x"},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1975.tb02746.x"},{"key":"e_1_2_1_35_1","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1182\/blood.V76.3.435.435","article-title":"Treatment of Cooley's anemia","volume":"7","author":"Fosburg M.T.","year":"1990","journal-title":"Blood"},{"key":"e_1_2_1_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0887-7963(88)70041-3"},{"key":"e_1_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0887-7963(94)70093-6"},{"key":"e_1_2_1_38_1","doi-asserted-by":"publisher","DOI":"10.1136\/adc.57.2.156"},{"key":"e_1_2_1_39_1","doi-asserted-by":"publisher","DOI":"10.1159\/000183793"},{"key":"e_1_2_1_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)92330-1"},{"key":"e_1_2_1_41_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1992.32592327719.x"},{"key":"e_1_2_1_42_1","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1182\/blood.V59.4.865.865","article-title":"A simple technique for preparation of young red cells for transfusion from ordinary blood units","volume":"59","author":"Graziano J.H.","year":"1982","journal-title":"Blood"},{"key":"e_1_2_1_43_1","doi-asserted-by":"publisher","DOI":"10.3109\/08880019209016592"},{"key":"e_1_2_1_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)92444-X"},{"key":"e_1_2_1_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/0268-960X(90)90011-G"},{"key":"e_1_2_1_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)90641-7"},{"key":"e_1_2_1_47_1","doi-asserted-by":"publisher","DOI":"10.1002\/jca.2920040411"},{"key":"e_1_2_1_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1990.tb07887.x"},{"key":"e_1_2_1_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)91224-6"},{"key":"e_1_2_1_50_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1992.32392213798.x"},{"key":"e_1_2_1_51_1","first-page":"392","article-title":"Leukocyte reduction of cellular blood components. Effectiveness, benefits, quality control and costs","volume":"118","author":"Lane T.A.","year":"1994","journal-title":"Archives of Pathology and Laboratory Medicine"},{"key":"e_1_2_1_52_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1994.34994378276.x"},{"key":"e_1_2_1_53_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199309163291204"},{"key":"e_1_2_1_54_1","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1182\/blood.V54.5.961.961","article-title":"Genetics of red cell and susceptibility to malaria","volume":"54","author":"Luzzatto L.","year":"1979","journal-title":"Blood"},{"key":"e_1_2_1_55_1","first-page":"131","article-title":"Toxic effects of high\u2010dose deferoxamine treatment in patients with iron overload; an electrophysiological study of cerebral and visual function","volume":"76","author":"Marciani M.G.","year":"1991","journal-title":"Haematologica"},{"key":"e_1_2_1_56_1","doi-asserted-by":"publisher","DOI":"10.1159\/000206267"},{"key":"e_1_2_1_57_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1985.tb07396.x"},{"key":"e_1_2_1_58_1","first-page":"792","article-title":"A multicenter study on the efficiency of white cell reduction by filtration of red cells","volume":"32","author":"Masse M.","year":"1992","journal-title":"Transfusion"},{"key":"e_1_2_1_59_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1991.31591263204.x"},{"key":"e_1_2_1_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)90906-6"},{"key":"e_1_2_1_61_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1987.tb02999.x"},{"key":"e_1_2_1_62_1","volume-title":"The Clinical Approach to Thalassaemia","author":"Modell B.","year":"1984"},{"key":"e_1_2_1_63_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.270.19.2338"},{"key":"e_1_2_1_64_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199205000-00009"},{"key":"e_1_2_1_65_1","first-page":"160","article-title":"Preventing transfusion\u2010acquired cytomegalovirus infection in infants","author":"Murphy M.F.","year":"1989","journal-title":"Lancet"},{"key":"e_1_2_1_66_1","first-page":"337","article-title":"Blood donor testing for HIV\u2010I\/II and HTLV\u2010I\/II","volume":"118","author":"Ness P.M.","year":"1994","journal-title":"Archives of Pathology & Laboratory Medicine"},{"key":"e_1_2_1_67_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1990.30991048786.x"},{"key":"e_1_2_1_68_1","first-page":"211","article-title":"The first report of HTLV\u2010I infection associated with blood transfusion in a thalassemic patient from Sicily, Italy (letter)","volume":"5","author":"Nunnari A.","year":"1992","journal-title":"Journal of Acquired Immune Deficiency Syndrome"},{"key":"e_1_2_1_69_1","first-page":"157","article-title":"Transmission of adult T\u2010cell leukemia virus (HTLV\u20101) through blood transfusion and its prevention","volume":"2","author":"Okochi K.","year":"1986","journal-title":"AIDS Research"},{"key":"e_1_2_1_70_1","first-page":"14","article-title":"The past, present and future status of L1","volume":"10","author":"Olivieri N.F.","year":"1994","journal-title":"TIF News"},{"key":"e_1_2_1_71_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198604033141402"},{"key":"e_1_2_1_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)92962-H"},{"key":"e_1_2_1_73_1","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1182\/blood.V79.10.2741.bloodjournal79102741","article-title":"Reduction of tissue iron stores and normalization of serum ferritin during treatment with the oral iron chelator L1 in thalassemia intermedia","volume":"79","author":"Olivieri N.F.","year":"1992","journal-title":"Blood"},{"key":"e_1_2_1_74_1","first-page":"272","article-title":"Deferoxamine in thalassemia major","volume":"332","author":"Olivieri N.F.","year":"1995","journal-title":"New England Journal of Medicine"},{"key":"e_1_2_1_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(86)91636-3"},{"key":"e_1_2_1_76_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1984.24685066812.x"},{"key":"e_1_2_1_77_1","first-page":"45","volume-title":"Thalassemia Today. The Mediterranean Experience","author":"Parravicini A.","year":"1987"},{"key":"e_1_2_1_78_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199301143280202"},{"key":"e_1_2_1_79_1","first-page":"139","volume-title":"Thalassemia 1990","author":"Piga A.","year":"1991"},{"key":"e_1_2_1_80_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1988.tb00198.x"},{"key":"e_1_2_1_81_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1989.29789369675.x"},{"key":"e_1_2_1_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8588(18)30431-3"},{"key":"e_1_2_1_83_1","doi-asserted-by":"publisher","DOI":"10.1159\/000205876"},{"key":"e_1_2_1_84_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830170210"},{"key":"e_1_2_1_85_1","first-page":"29","volume-title":"Thalassemia 1990","author":"Politis C.","year":"1991"},{"key":"e_1_2_1_86_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1989.29689318464.x"},{"key":"e_1_2_1_87_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1989.tb02028.x"},{"key":"e_1_2_1_88_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1989.tb00300.x"},{"key":"e_1_2_1_89_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1994.34594249063.x"},{"key":"e_1_2_1_90_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197606242942603"},{"key":"e_1_2_1_91_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1994.34194098599.x"},{"key":"e_1_2_1_92_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1989.29589284150.x"},{"key":"e_1_2_1_93_1","first-page":"122","article-title":"Transfusion reactions in thalassemia. A survey from the Cooleycare Programme","volume":"75","author":"Rebulla P.","year":"1990","journal-title":"Haematologica"},{"key":"e_1_2_1_94_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1988.tb05090.x"},{"key":"e_1_2_1_95_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1994.tb00272.x"},{"key":"e_1_2_1_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)90881-O"},{"key":"e_1_2_1_97_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3148.1992.tb00138.x"},{"key":"e_1_2_1_98_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1993.33293158044.x"},{"key":"e_1_2_1_99_1","first-page":"75","article-title":"Thalassaemia in Bombay the role of medical genetics in developing countries","volume":"68","author":"Sangani B.","year":"1990","journal-title":"Bulletin of the World Health Organization"},{"key":"e_1_2_1_100_1","first-page":"346","article-title":"Transfusion\u2010transmitted viral infections other than hepatitis and human immunodeficiency virus infection. Cytomegalovirus, Epstein\u2010Barr virus, human herpesvirus 6, and human parvovirus B19","volume":"118","author":"Sayers M.H.","year":"1994","journal-title":"Archives of Pathology & Laboratory Medicine"},{"key":"e_1_2_1_101_1","first-page":"350","article-title":"Bacteria in blood for transfusion. A review","volume":"118","author":"Sazama K.","year":"1994","journal-title":"Archives of Pathology & Laboratory Medicine"},{"key":"e_1_2_1_102_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0887-7963(88)70046-2"},{"key":"e_1_2_1_103_1","first-page":"455","article-title":"Acquired immunodeficiency syndrome (AIDS) in multitransfused children with thalassemia","volume":"30","author":"Sen S.","year":"1993","journal-title":"Indian Pediatrics"},{"key":"e_1_2_1_104_1","first-page":"366","article-title":"Parasitic infections and their impact on blood donor selection and testing","volume":"118","author":"Shulman I.A.","year":"1994","journal-title":"Archives of Pathology & Laboratory Medicine"},{"key":"e_1_2_1_105_1","first-page":"67S","article-title":"An improved questionnaire to select blood donors at risk of HIV infection","volume":"32","author":"Silvani C.","year":"1992","journal-title":"Transfusion"},{"key":"e_1_2_1_106_1","first-page":"59","volume-title":"Leucocyte Depletion of Blood Components. Present Trends and the Future","author":"Sirchia G.","year":"1994"},{"key":"e_1_2_1_107_1","first-page":"87","volume-title":"Progress in Transfusion Medicine","author":"Sirchia G.","year":"1988"},{"key":"e_1_2_1_108_1","first-page":"1","volume-title":"Controversies in Transfusion Medicine: Immune Complications and Cytomegalovirus Transmission","author":"Sirchia G.","year":"1990"},{"key":"e_1_2_1_109_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1982.tb01094.x"},{"key":"e_1_2_1_110_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1986.tb01986.x"},{"key":"e_1_2_1_111_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1994.34194098598.x"},{"key":"e_1_2_1_112_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1985.25285169198.x"},{"key":"e_1_2_1_113_1","first-page":"109","article-title":"A prospective study on the use of leucocyte\u2010filters in reducing blood transfusion reactions in multi\u2010transfused thalassemic children","volume":"34","author":"Tan K.K.","year":"1993","journal-title":"Singapore Medical Journal"},{"key":"e_1_2_1_114_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1990.tb07915.x"},{"key":"e_1_2_1_115_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1994.tb04884.x"},{"key":"e_1_2_1_116_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198802253180803"},{"key":"e_1_2_1_117_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1991.31291142947.x"},{"key":"e_1_2_1_118_1","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1182\/blood.V83.10.3028.3028","article-title":"Bedside filtration of blood products in the prevention of HLA alloimmunization \u2010 A prospective randomized study","volume":"83","author":"Williamson L.M.","year":"1994","journal-title":"Blood"},{"key":"e_1_2_1_119_1","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.43.8.638"},{"key":"e_1_2_1_120_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)90264-X"}],"container-title":["Transfusion Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-3148.1995.tb00210.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-3148.1995.tb00210.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T19:18:29Z","timestamp":1695842309000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-3148.1995.tb00210.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,12]]},"references-count":119,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1995,12]]}},"alternative-id":["10.1111\/j.1365-3148.1995.tb00210.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-3148.1995.tb00210.x","archive":["Portico"],"relation":{},"ISSN":["0958-7578","1365-3148"],"issn-type":[{"value":"0958-7578","type":"print"},{"value":"1365-3148","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,12]]},"assertion":[{"value":"2008-06-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}